Table 2 Animal information and SD 31 treatment dosages (Groups 1–5)
Treatment group | Animal identification | Sex | Body weight (lb) | ||||
|---|---|---|---|---|---|---|---|
Ivermectin/Pyrantel | Tablet administered | Dose | |||||
(Group 1) | Ivermectin (μg) | Pyrantel (mg) | Ivermectin (μg/kg) | Pyrantel (mg/kg) | |||
IDF-2 | M | 28.9 | 136 | 114 | 10.4 | 8.7 | |
UHH-2 | M | 25.8 | 136 | 114 | 11.6 | 9.7 | |
VTH-2 | M | 23.7 | 68 | 57 | 6.3 | 5.3 | |
IOF-2 | M | 23.1 | 68 | 57 | 6.5 | 5.4 | |
BFG-2 | F | 23.0 | 68 | 57 | 6.5 | 5.5 | |
PXC-2 | F | 20.4 | 68 | 57 | 7.3 | 6.1 | |
VVH-2 | M | 21.2 | 68 | 57 | 7.1 | 5.9 | |
GSC-2 | F | 19.4 | 68 | 57 | 7.7 | 6.5 | |
Milbemycin/Spinosad | Tablet administered | Dose | |||||
(Group 2) | Milbemycin (mg) | Spinosad (mg) | Milbemycin (mg/kg) | Spinosad (mg/kg) | |||
FCG-2 | F | 23.5 | 9.3 | 560 | 0.9 | 52.4 | |
IUE-2 | F | 25.7 | 9.3 | 560 | 0.8 | 47.9 | |
UDH-2 | M | 23.4 | 9.3 | 560 | 0.9 | 52.6 | |
VCG-2 | F | 22.4 | 9.3 | 560 | 0.9 | 55.0 | |
TPH-2 | M | 26.7 | 9.3 | 560 | 0.8 | 46.1 | |
XBH-2 | M | 21.4 | 9.3 | 560 | 1.0 | 57.6 | |
EZG-2 | F | 22.5 | 9.3 | 560 | 0.9 | 54.8 | |
KUH-2 | M | 18.4 | 4.5 | 270 | 0.5 | 32.3 | |
Applicator tube | Dose | ||||||
Selamectin | Selamectin (mg) | Selamectin (mg/kg) | |||||
(Group 3) | OFF-2 | M | 25.5 | 120 | 10.4 | ||
VUH-2 | M | 24.1 | 120 | 11.0 | |||
EYE-2 | F | 23.0 | 120 | 11.5 | |||
UKG-2 | F | 21.6 | 120 | 12.2 | |||
AVG-2 | F | 22.3 | 120 | 11.8 | |||
GPG-2 | F | 20.7 | 120 | 12.8 | |||
GDE-2 | F | 20.8 | 120 | 12.7 | |||
ZXG-2 | F | 19.0 | 60 | 6.9 | |||
Moxidectin/ Imidacloprid | Applicator tube | Dose | |||||
(Group 4) | Moxidectin (mg) | Imidacloprid (mg) | Moxidectin (mg/kg) | Imidaclopridd (mg/kg) | |||
DIH-2 | M | 24.4 | NA | NA | NA | NA | |
UYH-2 | M | 27.1 | NA | NA | NA | NA | |
CGH-2 | M | 23.6 | NA | NA | NA | NA | |
FKC-2 | F | 22.1 | NA | NA | NA | NA | |
FJC-2 | F | 20.8 | NA | NA | NA | NA | |
VZG-2 | F | 20.6 | NA | NA | NA | NA | |
LAG-2 | F | 20.7 | NA | NA | NA | NA | |
THH-2 | M | 19.1 | NA | NA | NA | NA | |
Non-treated control | |||||||
(Group 5) | UTH-2 | M | 28.1 | NA | NA | NA | NA |
GKC-2 | F | 25.2 | NA | NA | NA | NA | |
TWH-2 | M | 22.8 | NA | NA | NA | NA | |
EDG-2 | F | 21.5 | NA | NA | NA | NA | |
RAF-2 | M | 23.5 | NA | NA | NA | NA | |
CRC-2 | F | 21.6 | NA | NA | NA | NA | |
TJH-2 | M | 22.5 | NA | NA | NA | NA | |
IXG-2 | F | 19.5 | NA | NA | NA | NA | |